-
Unless contraindicated, all patients with diabetes should be treated with aspirin 100 mg orally daily for secondary prevention (i.e. a previous vascular event)
-
Clopidogrel may be used as an alternative if aspirin is not tolerated
-
The benefits of aspirin for primary prevention are decreased and the risks of bleeding are increased in patients with diabetes.
-
Generally aspirin for primary prevention should only be considered in patients with a 5 year CVD risk > 15% with a low risk of bleeding